Adverum
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
100 Cardinal Way, Redwood City, Californ...Phone Number
(650) 656-9323Website
www.adverum.comRevenue
-Stock Symbol
ADVMIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
1
1
1
About Adverum
Adverum Biotechnologies is a biotechnology company focused on the development of gene therapy solutions intended to transform the treatment of serious ocular diseases. The organization is dedicated to advancing innovative therapeutic approaches that seek to restore vision, preserve eyesight, and reduce the burden associated with chronic retinal conditions. Through its proprietary gene therapy platform, the company develops treatments designed to provide durable therapeutic benefits following a single administration, potentially reducing the need for repeated interventions that are commonly required under current standards of care. The company operates within the biotechnology and life sciences sector, concentrating its scientific efforts on ophthalmology. Its research activities focus on utilizing adeno-associated virus vector technology to deliver therapeutic genetic material directly to targeted tissues within the eye. This approach is intended to enable retinal cells to continuouslyRead more
Adverum Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Adverum your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Adverum is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Adverum launches new products
Adverum, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Adverum
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Adverum had a recent Job posting/layoffs
Earning: See what the market has to say on Adverum recently announced quarterly report
Funding: Get notified immidiatlly once Adverum has new funding data
Check if Adverum has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Adverum
Find 3 more new buyers
Compare Similar Companies to Adverum
Compare insights from companies similar to Adverum, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Adverum is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Adverum is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Adverum.
Adverum financials insights
Gather financial insights about Adverum, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Stock Offering
$102M
2020
Stock Offering
$150.2M
Adverum Tech Stack
A closer look at the technologies used by Adverum
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Hiring Plans
Adverum has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Technologies mentioned include: Redwood Software. Areas of expertise include: Biopharmaceutical Manufacturing, Statistics, Biochemical Engineering, Assay Development, Filtration, Buffer Preparation, and Column Chromatography.
Hiring Plans
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Adverum News & Media
Adverum Reminds Stockholders to Tender their Shares into the Offer by Lilly
Mails Letter to Stockholders Highlighting the Certainty of Value the Transaction Delivers to Stockholders Compared to a Liquidation Mails Letter to Stockholders Highlighting the Certainty of Value the Transaction Delivers to Stockholders Compared to a LiquidationEli Lilly Strengthens Gene Therapy Portfolio Through Adverum Acquisition
Adverum Therapeutics has been acquired by Eli Lilly to strengthen its gene therapy portfolio in a deal that could be worth $260 million.Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration
REDWOOD CITY, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of intravitreal gene therapy as a potential One And DoneTM treatment to preserve sight for life, today announced it has notified sites that it plans to complete screening in ARTEMIS, its first pivotal Phase 3 trial evaluating Ixo-vec in wet age-related macular degeneration (wet AMD) by September 30, seven months after initiation, because the companyTrexquant Slashes Stake in Adverum Biotechnologies, Inc. (ADVM) - Insider Monkey
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) is among the best fundamentally strong penny stocks to buy right now.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Adverum
Sign Up For FreeTo access detailed company insights
Adverum Biotechnologies is a biotechnology company focused on the development of gene therapy solutions intended to transform the treatment of serious ocular diseases. The organization is dedicated to advancing innovative therapeutic approaches that seek to restore vision, preserve eyesight, and reduce the burden associated with chronic retinal con... Read More
